These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 197165)

  • 1. Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.
    Clancy R; Rawls WE; Jagannath S
    J Immunol; 1977 Sep; 119(3):1102-5. PubMed ID: 197165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
    Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
    J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
    Shore SL; Melewicz FM; Gordon DS
    J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the interrelation of resistance and immunity in a mouse model system of herpes-simplex type 2 infection.
    Armerding D
    Immunobiology; 1982 May; 161(5):415-28. PubMed ID: 6284636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
    Meyers-Elliott RH; Chitjian PA
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
    Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
    J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity.
    Carter VC; Schaffer PA; Tevethia SS
    J Immunol; 1981 May; 126(5):1655-60. PubMed ID: 6971309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
    Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat.
    Tompkins MB; Tompkins WA
    J Immunol; 1985 Oct; 135(4):2817-23. PubMed ID: 2993416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression.
    Cappel R; Gregoire F; Thiry L; Sprecher S
    J Clin Psychiatry; 1978 Mar; 39(3):266-8. PubMed ID: 204625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.